Skip to main content
. 2023 May 17;22:39. doi: 10.1186/s12941-023-00587-x

Table 1.

DS to ceftriaxone/cefixime and dual antibiotic resistance of 50 DS isolates

A. Ceftriaxone or/and cefixime DS in different regions
Region DSC isolates Ceftriaxone-DS Cefixime-DS Ceftriaxone/Cefixime-DS
Isolates % Isolates % Isolates %
Pearl River Delta 29 5 17.24 10 34.48 14 48.28
East Guangdong 9 2 22.22 4 44.44 3 33.33
North Guangdong 9 0 0.00 5 55.56 4 44.44
West Guangdong 3 1 33.33 0 0.00 2 66.67
Total 50 8 16.00 19 38.00 23 46.00
B. Dual antibiotic resistance of isolates with DSC in different regions
Region DSC isolates DSC + PEN DSC + TET DSC + CIP DSC + SPT DSC + AZI
Isolates % Isolates % Isolates % Isolates % Isolates %
Pearl river Delta 29 28 96.5 29 100.0 29 100.0 0 0.0 2 6.9
East Guangdong 9 9 100.0 8 88.9 9 100.0 0 0.0 2 22.2
North Guangdong 9 8 88.9 9 100.0 9 100.0 0 0.0 1 11.1
West Guangdong 3 3 100.0 3 100.0 3 100.0 0 0.0 0 0.0
Total 50 48 96.0 49 98.0 50 100.0 0 0.0 5 10.0

DSC Decreased susceptibility to cephalosporins (ceftriaxone or cefixime); CRO Ceftriaxone; CFM Cefixime; PEN Penicillin, TET Tetracycline, CIP Ciprofloxacin, SPT Spectinomycin, AZI Azithromycin